Advanced search
Publication Cover
Personalized Medicine Volume 9, 2012 - Issue 4
Submit an article Journal homepage
427
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Thyroid Cancer Genetics: How Close are we to Personalizing Clinical Management?

Joanne Ngeowa Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, NE-50, Cleveland, OH 44195, USA and Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USAView further author information
&
Charis Engb Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, NE-50, Cleveland, OH 44195, USA and Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA and Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA and Thyroid Cancer Center, Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH 44195, USA and Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic, Cleveland, OH 44195, USA and Department of Genetics, & CASE Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.Correspondence[email protected]
View further author information
Pages 355-358 | Published online: 18 Jun 2012

References

  • Davies L , WelchHG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA295(18) , 2164–2167 (2006).
  • Chen AY , JemalA, WardEM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer115(16) , 3801–3807 (2009).
  • Richards ML . Familial syndromes associated with thyroid cancer in the era of personalized medicine. Thyroid20(7) , 707–713 (2010).
  • Zbuk KM , EngC. Cancer phenomics: RET and PTEN as illustrative models. Nat. Rev. Cancer7(1) , 35–45 (2007).
  • Nikiforov YE , NikiforovaMN. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol.7(10) , 569–580 (2011).
  • Kloos RT , EngC, EvansDB et al. Medullary thyroid cancer: management guidelines of the American thyroid association. Thyroid 19(6) , 565–612 (2009).
  • Wells SA Jr, Gosnell JE, Gagel RF et al. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J. Clin. Oncol.28(5) , 767–772 (2010).
  • Tan MH , MesterJL, NgeowJ, RybickiLA, OrloffMS, EngC. Lifetime cancer risks in individuals with germline PTEN mutations. Clin. Cancer Res.18(2) , 400–407 (2012).
  • Ngeow J , MesterJ, RybickiLA, NiY, MilasM, EngC. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J. Clin. Endocrinol. Metab.96(12) , E2063–E2071 (2011).
  • Bennett KL , MesterJ, EngC. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA304(24) , 2724–2731 (2010).
  • Ni Y , ZbukKM, SadlerT et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am. J. Hum. Genet. 83(2) , 261–268 (2008).
  • Mester JL , ZhouM, PrescottN, EngC. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology79(5) , 1187.e1–e7 (2012).
  • Ni Y , HeX, ChenJ et al. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum. Mol. Genet. 21(2) , 300–310 (2012).
  • Kimura ET , NikiforovaMN, ZhuZ, KnaufJA, NikiforovYE, FaginJA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC–RAS–BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res.63(7) , 1454–1457 (2003).
  • Xing M . Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol. Cell. Endocrinol.321(1) , 86–93 (2010).
  • Nikiforova MN , LynchRA, BiddingerPW et al. RAS point mutations and PAX8-PPAR γ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J. Clin. Endocrinol. Metab.88(5) , 2318–2326 (2003).
  • Kroll TG , SarrafP, PecciariniL et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289(5483) , 1357–1360 (2000).
  • Weber F , ShenL, AldredMA et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J. Clin. Endocrinol. Metab. 90(5) , 2512–2521 (2005).
  • Weber F , EngC. Update on the molecular diagnosis of endocrine tumors: toward -omics-based personalized healthcare? J. Clin. Endocrinol. Metab.93(4) , 1097–1104 (2008).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.